{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:18:05Z","timestamp":1788250685845,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T00:00:00Z","timestamp":1668729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100008129","name":"Helsinn","doi-asserted-by":"publisher","award":["Helsinn Healthcare SA"],"award-info":[{"award-number":["Helsinn Healthcare SA"]}],"id":[{"id":"10.13039\/100008129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s40257-022-00732-w","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T11:03:41Z","timestamp":1668769421000},"page":"5-14","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion\u00a0"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1645-8038","authenticated-orcid":false,"given":"Emmilia","family":"Hodak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Geskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuella","family":"Guenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo L.","family":"Ortiz-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rein","family":"Willemze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Foss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Querfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,18]]},"reference":[{"issue":"10","key":"732_CR1","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","volume":"105","author":"R Willemze","year":"2005","unstructured":"Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768\u201385. https:\/\/doi.org\/10.1182\/blood-2004-09-3502.","journal-title":"Blood"},{"issue":"10","key":"732_CR2","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.3390\/cancers12102921","volume":"12","author":"G Dobos","year":"2020","unstructured":"Dobos G, Pohrt A, Ram-Wolff C, Lebb\u00e9 C, Bouaziz JD, Battistella M, et al. Epidemiology of cutaneous T-cell lymphomas: a systematic review and meta-analysis of 16,953 patients. Cancers (Basel). 2020;12(10):2921. https:\/\/doi.org\/10.3390\/cancers12102921.","journal-title":"Cancers (Basel)."},{"issue":"10","key":"732_CR3","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1111\/jdv.16325","volume":"34","author":"AE Kaufman","year":"2020","unstructured":"Kaufman AE, Patel K, Goyal K, O\u2019Leary D, Rubin N, Pearson D, et al. Mycosis fungoides: developments in incidence, treatment and survival. J Eur Acad Dermatol Venereol. 2020;34(10):2288\u201394. https:\/\/doi.org\/10.1111\/jdv.16325.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"732_CR4","doi-asserted-by":"publisher","first-page":"adv00013","DOI":"10.2340\/00015555-3367","volume":"100","author":"A Maguire","year":"2020","unstructured":"Maguire A, Puelles J, Raboisson P, Chavda R, Gabriel S, Thornton S. Early-stage mycosis fungoides: epidemiology and prognosis. Acta Derm Venereol. 2020;100(1):adv00013. https:\/\/doi.org\/10.2340\/00015555-3367.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"732_CR5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/bjd.20048","volume":"185","author":"R Ottevanger","year":"2021","unstructured":"Ottevanger R, de Bruin DT, Willemze R, Jansen PM, Bekkenk MW, de Haas ERM, et al. Incidence of mycosis fungoides and Sezary syndrome in the Netherlands between 2000 and 2020. Br J Dermatol. 2021;185(2):434\u20135. https:\/\/doi.org\/10.1111\/bjd.20048.","journal-title":"Br J Dermatol"},{"issue":"1","key":"732_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.hoc.2018.09.001","volume":"33","author":"C Larocca","year":"2019","unstructured":"Larocca C, Kupper T. Mycosis fungoides and Sezary syndrome: an update. Hematol Oncol Clin N Am. 2019;33(1):103\u201320. https:\/\/doi.org\/10.1016\/j.hoc.2018.09.001.","journal-title":"Hematol Oncol Clin N Am"},{"issue":"1","key":"732_CR7","first-page":"92","volume":"6","author":"J Scarisbrick","year":"2018","unstructured":"Scarisbrick J. Staging of mycosis fungoides and S\u00e9zary syndrome: time for an update? EMJ Allergy Immunol. 2018;6(1):92\u2013100.","journal-title":"EMJ Allergy Immunol"},{"issue":"6","key":"732_CR8","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"E Olsen","year":"2007","unstructured":"Olsen E, Whittaker S, Willemze R, Pinter-Brown L, Foss F,  Geskin L, et al.  Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from ISCL, USCLC, and EORTC.  Blood. 2022;140(5):419\u201337. https:\/\/doi.org\/10.1182\/blood-2007-03-055749.","journal-title":"Blood"},{"issue":"31","key":"732_CR9","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","volume":"28","author":"NS Agar","year":"2010","unstructured":"Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, et al. Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol. 2010;28(31):4730\u20139. https:\/\/doi.org\/10.1200\/JCO.2009.27.7665.","journal-title":"J Clin Oncol"},{"issue":"10","key":"732_CR10","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/cncr.22252","volume":"107","author":"MF Demierre","year":"2006","unstructured":"Demierre MF, Gan S, Jones J, Miller DR. Significant impact of cutaneous T-cell lymphoma on patients\u2019 quality of life: results of a 2005 National Cutaneous Lymphoma Foundation Survey. Cancer. 2006;107(10):2504\u201311. https:\/\/doi.org\/10.1002\/cncr.22252.","journal-title":"Cancer"},{"issue":"3","key":"732_CR11","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/bjd.18089","volume":"182","author":"K Molloy","year":"2020","unstructured":"Molloy K, Jonak C, Woei AJF, Guenova E, Busschots AM, Bervoets A, et al. Characteristics associated with significantly worse quality of life in mycosis fungoides\/Sezary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. Br J Dermatol. 2020;182(3):770\u20139. https:\/\/doi.org\/10.1111\/bjd.18089.","journal-title":"Br J Dermatol"},{"key":"732_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jdcr.2020.12.010","volume":"8","author":"K Russomanno","year":"2021","unstructured":"Russomanno K, Carver DeKlotz CM. Acceleration of cutaneous T-cell lymphoma following dupilumab administration. JAAD Case Rep. 2021;8:83\u20135. https:\/\/doi.org\/10.1016\/j.jdcr.2020.12.010.","journal-title":"JAAD Case Rep."},{"issue":"2","key":"732_CR13","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.12788\/cutis.0074","volume":"106","author":"LC Hollins","year":"2020","unstructured":"Hollins LC, Wirth P, Fulchiero GJ Jr, Foulke GT. Long-standing dermatitis treated with dupilumab with subsequent progression to cutaneous T-cell lymphoma. Cutis. 2020;106(2):E8\u201311. https:\/\/doi.org\/10.12788\/cutis.0074.","journal-title":"Cutis"},{"issue":"6","key":"732_CR14","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jaad.2017.12.068","volume":"78","author":"ME Martinez-Escala","year":"2018","unstructured":"Martinez-Escala ME, Posligua AL, Wickless H, Rutherford A, Sable KA, Rubio-Gonzalez B, et al. Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor-alpha therapy. J Am Acad Dermatol. 2018;78(6):1068\u201376. https:\/\/doi.org\/10.1016\/j.jaad.2017.12.068.","journal-title":"J Am Acad Dermatol"},{"issue":"16","key":"732_CR15","doi-asserted-by":"publisher","first-page":"adv00277","DOI":"10.2340\/00015555-3642","volume":"100","author":"I Amitay-Laish","year":"2020","unstructured":"Amitay-Laish I, Guenova E, Ortiz-Romero PL, Vico-Alonso C, Rozati S, Geskin LJ, et al. The course of mycosis fungoides under cytokine pathway blockers: a multicentre analysis of real-life clinical data. Acta Derm Venereol. 2020;100(16):adv00277. https:\/\/doi.org\/10.2340\/00015555-3642.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"732_CR16","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1080\/09546634.2017.1365113","volume":"29","author":"JW Hoot","year":"2018","unstructured":"Hoot JW, Wang L, Kho T, Akilov OE. The effect of phototherapy on progression to tumors in patients with patch and plaque stage of mycosis fungoides. J Dermatol Treat. 2018;29(3):272\u20136. https:\/\/doi.org\/10.1080\/09546634.2017.1365113.","journal-title":"J Dermatol Treat"},{"issue":"4","key":"732_CR17","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1001\/archderm.136.4.504","volume":"136","author":"R van Doorn","year":"2000","unstructured":"van Doorn R, Van Haselen CW, van Voorst Vader PC, Geerts ML, Heule F, de Rie M, et al. Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients. Arch Dermatol. 2000;136(4):504\u201310. https:\/\/doi.org\/10.1001\/archderm.136.4.504.","journal-title":"Arch Dermatol"},{"issue":"1","key":"732_CR18","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/j.jaad.2019.09.001","volume":"82","author":"F Pavlotsky","year":"2020","unstructured":"Pavlotsky F, Hodak E, Dawood M, Barzilai A. Stage IA mycosis fungoides should be treated until proven otherwise. J Am Acad Dermatol. 2020;82(1):e19\u201320. https:\/\/doi.org\/10.1016\/j.jaad.2019.09.001.","journal-title":"J Am Acad Dermatol"},{"key":"732_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejca.2017.02.027","volume":"77","author":"F Trautinger","year":"2017","unstructured":"Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, et al. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides\/Sezary syndrome\u2014update 2017. Eur J Cancer. 2017;77:57\u201374. https:\/\/doi.org\/10.1016\/j.ejca.2017.02.027.","journal-title":"Eur J Cancer"},{"issue":"Suppl 4","key":"732_CR20","doi-asserted-by":"publisher","first-page":"iv30","DOI":"10.1093\/annonc\/mdy133","volume":"29","author":"R Willemze","year":"2018","unstructured":"Willemze R, Hodak E, Zinzani PL, Specht L, Ladetto M, Committee EG. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv30\u201340. https:\/\/doi.org\/10.1093\/annonc\/mdy133.","journal-title":"Ann Oncol"},{"key":"732_CR21","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae). Primary Cutaneous Lymphomas. Version 2.2021. 2020. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/primary_cutaneous.pdf. Accessed 28 July, 2021."},{"issue":"4","key":"732_CR22","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/bjd.19252","volume":"184","author":"P Quaglino","year":"2021","unstructured":"Quaglino P, Prince HM, Cowan R, Vermeer M, Papadavid E, Bagot M, et al. Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. Br J Dermatol. 2021;184(4):722\u201330. https:\/\/doi.org\/10.1111\/bjd.19252.","journal-title":"Br J Dermatol"},{"issue":"3","key":"732_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.clindermatol.2019.01.004","volume":"37","author":"E Hodak","year":"2019","unstructured":"Hodak E, Amitay-Laish I. Mycosis fungoides: a great imitator. Clin Dermatol. 2019;37(3):255\u201367. https:\/\/doi.org\/10.1016\/j.clindermatol.2019.01.004.","journal-title":"Clin Dermatol"},{"issue":"6","key":"732_CR24","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","volume":"53","author":"N Pimpinelli","year":"2005","unstructured":"Pimpinelli N, Olsen EA, Santucci M, Vonderheid E, Haeffner AC, Stevens S, et al. Defining early mycosis fungoides. J Am Acad Dermatol. 2005;53(6):1053\u201363. https:\/\/doi.org\/10.1016\/j.jaad.2005.08.057.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"732_CR25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/bjd.17258","volume":"181","author":"JJ Scarisbrick","year":"2019","unstructured":"Scarisbrick JJ, Quaglino P, Prince HM, Papadavid E, Hodak E, Bagot M, et al. The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients. Br J Dermatol. 2019;181(2):350\u20137. https:\/\/doi.org\/10.1111\/bjd.17258.","journal-title":"Br J Dermatol"},{"issue":"4","key":"732_CR26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/archderm.136.4.497","volume":"136","author":"M Santucci","year":"2000","unstructured":"Santucci M, Biggeri A, Feller AC, Burg G, For the European Organization for Research, Treatment of Cancer Cutaneous Lymphoma Project Group. Accuracy, concordance, and reproducibility of histologic diagnosis in cutaneous t-cell lymphoma: An EORTC Cutaneous Lymphoma Project Group study. Arch Dermatol. 2000;136(4):497\u2013502. https:\/\/doi.org\/10.1001\/archderm.136.4.497.","journal-title":"Arch Dermatol"},{"issue":"6","key":"732_CR27","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1590\/abd1806-4841.20132336","volume":"88","author":"FC Furlan","year":"2013","unstructured":"Furlan FC, Sanches JA. Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology. Bras Dermatol. 2013;88(6):954\u201360. https:\/\/doi.org\/10.1590\/abd1806-4841.20132336.","journal-title":"Bras Dermatol"},{"issue":"2","key":"732_CR28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/107327480701400203","volume":"14","author":"CA Keehn","year":"2007","unstructured":"Keehn CA, Belongie IP, Shistik G, Fenske NA, Glass LF. The diagnosis, staging, and treatment options for mycosis fungoides. Cancer Control. 2007;14(2):102\u201311. https:\/\/doi.org\/10.1177\/107327480701400203.","journal-title":"Cancer Control"},{"key":"732_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00716-y","author":"M Chairatchaneeboon","year":"2022","unstructured":"Chairatchaneeboon M, Thanomkitti K, Kim EJ. Parapsoriasis\u2014a diagnosis with an identity crisis: a narrative review. Dermatol Ther. 2022. https:\/\/doi.org\/10.1007\/s13555-022-00716-y.","journal-title":"Dermatol Ther"},{"issue":"4","key":"732_CR30","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1080\/00015550510030087","volume":"85","author":"L Vakeva","year":"2005","unstructured":"Vakeva L, Sarna S, Vaalasti A, Pukkala E, Kariniemi AL, Ranki A. A retrospective study of the probability of the evolution of parapsoriasis en plaques into mycosis fungoides. Acta Dermatovenereol. 2005;85(4):318\u201323. https:\/\/doi.org\/10.1080\/00015550510030087.","journal-title":"Acta Dermatovenereol"},{"issue":"5","key":"732_CR31","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1001\/archderm.1996.03890290101014","volume":"132","author":"G Burg","year":"1996","unstructured":"Burg G, Dummer R, Nestle FO, Doebbeling U, Haeffner A. Cutaneous lymphomas consist of a spectrum of nosologically different entities including mycosis fungoides and small plaque parapsoriasis. Arch Dermatol. 1996;132(5):567\u201372.","journal-title":"Arch Dermatol"},{"issue":"3","key":"732_CR32","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jaad.2008.05.028","volume":"59","author":"IE Belousova","year":"2008","unstructured":"Belousova IE, Vanecek T, Samtsov AV, Michal M, Kazakov DV. A patient with clinicopathologic features of small plaque parapsoriasis presenting later with plaque-stage mycosis fungoides: report of a case and comparative retrospective study of 27 cases of \u201cnonprogressive\u201d small plaque parapsoriasis. J Am Acad Dermatol. 2008;59(3):474\u201382. https:\/\/doi.org\/10.1016\/j.jaad.2008.05.028.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"732_CR33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1034\/j.1600-0560.2001.028004174.x","volume":"28","author":"J Guitart","year":"2001","unstructured":"Guitart J, Kennedy J, Ronan S, Chmiel JS, Hsiegh YC, Variakojis D. Histologic criteria for the diagnosis of mycosis fungoides: proposal for a grading system to standardize pathology reporting. J Cutan Pathol. 2001;28(4):174\u201383. https:\/\/doi.org\/10.1034\/j.1600-0560.2001.028004174.x.","journal-title":"J Cutan Pathol"},{"issue":"6","key":"732_CR34","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1067\/mjd.2002.124696","volume":"47","author":"HS Zackheim","year":"2002","unstructured":"Zackheim HS, McCalmont TH. Mycosis fungoides: the great imitator. J Am Acad Dermatol. 2002;47(6):914\u20138. https:\/\/doi.org\/10.1067\/mjd.2002.124696.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"732_CR35","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1309\/AJCPOBDP2OQAJ5BR","volume":"139","author":"SX Song","year":"2013","unstructured":"Song SX, Willemze R, Swerdlow SH, Kinney MC, Said JW. Mycosis fungoides: report of the 2011 Society for Hematopathology\/European Association for Haematopathology workshop. Am J Clin Pathol. 2013;139(4):466\u201390. https:\/\/doi.org\/10.1309\/AJCPOBDP2OQAJ5BR.","journal-title":"Am J Clin Pathol"},{"key":"732_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2020.151546","volume":"47","author":"A Alsayyah","year":"2020","unstructured":"Alsayyah A. Is it mycosis fungoides? A comprehensive guide to reaching the diagnosis and avoiding common pitfalls. Ann Diagn Pathol. 2020;47: 151546. https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151546.","journal-title":"Ann Diagn Pathol"},{"issue":"4","key":"732_CR37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.mpdhp.2016.04.004","volume":"22","author":"P Virmani","year":"2016","unstructured":"Virmani P, Myskowski PL, Pulitzer M. Unusual variants of mycosis fungoides. Diagn Histopathol (Oxf). 2016;22(4):142\u201351. https:\/\/doi.org\/10.1016\/j.mpdhp.2016.04.004.","journal-title":"Diagn Histopathol (Oxf)."},{"issue":"16","key":"732_CR38","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","volume":"133","author":"R Willemze","year":"2019","unstructured":"Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703\u201314. https:\/\/doi.org\/10.1182\/blood-2018-11-881268.","journal-title":"Blood"},{"issue":"2","key":"732_CR39","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jaad.2006.01.020","volume":"55","author":"E Hodak","year":"2006","unstructured":"Hodak E, David M, Maron L, Aviram A, Kaganovsky E, Feinmesser M. CD4\/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides. J Am Acad Dermatol. 2006;55(2):276\u201384. https:\/\/doi.org\/10.1016\/j.jaad.2006.01.020.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"732_CR40","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1365-2133.2009.09301.x","volume":"161","author":"VA Nikolaou","year":"2009","unstructured":"Nikolaou VA, Papadavid E, Katsambas A, Stratigos AJ, Marinos L, Anagnostou D, et al. Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients. Br J Dermatol. 2009;161(4):826\u201330. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09301.x.","journal-title":"Br J Dermatol"},{"issue":"9","key":"732_CR41","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.3390\/diagnostics11091721","volume":"11","author":"T Miyagaki","year":"2021","unstructured":"Miyagaki T. Diagnosis of early mycosis fungoides. Diagnostics (Basel). 2021;11(9):1721. https:\/\/doi.org\/10.3390\/diagnostics11091721.","journal-title":"Diagnostics (Basel)."},{"issue":"5","key":"732_CR42","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/cup.12470","volume":"42","author":"T Vandergriff","year":"2015","unstructured":"Vandergriff T, Nezafati KA, Susa J, Karai L, Sanguinetti A, Hynan LS, et al. Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous Lymphomas. J Cutan Pathol. 2015;42(5):318\u201328. https:\/\/doi.org\/10.1111\/cup.12470.","journal-title":"J Cutan Pathol"},{"issue":"5","key":"732_CR43","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jaad.2007.06.004","volume":"57","author":"SE Thurber","year":"2007","unstructured":"Thurber SE, Zhang B, Kim YH, Schrijver I, Zehnder J, Kohler S. T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides. J Am Acad Dermatol. 2007;57(5):782\u201390. https:\/\/doi.org\/10.1016\/j.jaad.2007.06.004.","journal-title":"J Am Acad Dermatol"},{"issue":"440","key":"732_CR44","doi-asserted-by":"publisher","first-page":"eaar5894","DOI":"10.1126\/scitranslmed.aar5894","volume":"10","author":"A de Masson","year":"2018","unstructured":"de Masson A, O\u2019Malley JT, Elco CP, Garcia SS, Divito SJ, Lowry EL, et al. High-throughput sequencing of the T cell receptor \u03b2 gene identifies aggressive early-stage mycosis fungoides. Sci Transl Med. 2018;10(440):eaar5894. https:\/\/doi.org\/10.1126\/scitranslmed.aar5894.","journal-title":"Sci Transl Med"},{"issue":"1","key":"732_CR45","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3892\/or.2020.7865","volume":"45","author":"JD Gibbs","year":"2021","unstructured":"Gibbs JD, Ma S, Kim A, Seminario-Vidal L, Sokol L, Zhang H, et al. Utility of flow cytometry and gene rearrangement analysis in tissue and blood of patients with suspected cutaneous Tcell lymphoma. Oncol Rep. 2021;45(1):349\u201358. https:\/\/doi.org\/10.3892\/or.2020.7865.","journal-title":"Oncol Rep"},{"issue":"9","key":"732_CR46","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1136\/jclinpath-2018-205004","volume":"71","author":"B Rea","year":"2018","unstructured":"Rea B, Haun P, Emerson R, Vignali M, Farooqi M, Samimi S, et al. Role of high-throughput sequencing in the diagnosis of cutaneous T-cell lymphoma. J Clin Pathol. 2018;71(9):814\u201320. https:\/\/doi.org\/10.1136\/jclinpath-2018-205004.","journal-title":"J Clin Pathol"},{"issue":"4","key":"732_CR47","doi-asserted-by":"publisher","first-page":"413","DOI":"10.23736\/S2784-8671.20.06668-7","volume":"156","author":"VS Alberti","year":"2021","unstructured":"Alberti VS, Alaibac M, Ardigo M, Baldo A, Dim N, Massone C, et al. An expert consensus report on mycosis fungoides in Italy: epidemiological impact and diagnostic-therapeutic pathway. Ital J Dermatol Venereol. 2021;156(4):413\u201321. https:\/\/doi.org\/10.23736\/S2784-8671.20.06668-7.","journal-title":"Ital J Dermatol Venereol"},{"issue":"6","key":"732_CR48","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/bjd.12578","volume":"169","author":"BO Dulmage","year":"2013","unstructured":"Dulmage BO, Geskin LJ. Lessons learned from gene expression profiling of cutaneous T-cell lymphoma. Br J Dermatol. 2013;169(6):1188\u201397. https:\/\/doi.org\/10.1111\/bjd.12578.","journal-title":"Br J Dermatol"},{"issue":"5","key":"732_CR49","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1306618","volume":"6","author":"IV Litvinov","year":"2017","unstructured":"Litvinov IV, Tetzlaff MT, Thibault P, Gangar P, Moreau L, Watters AK, et al. Gene expression analysis in cutaneous t-cell lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators. Oncoimmunology. 2017;6(5): e1306618. https:\/\/doi.org\/10.1080\/2162402X.2017.1306618.","journal-title":"Oncoimmunology."},{"issue":"9","key":"732_CR50","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00403-014-1501-7","volume":"306","author":"S Morimura","year":"2014","unstructured":"Morimura S, Sugaya M, Suga H, Miyagaki T, Ohmatsu H, Fujita H, et al. TOX expression in different subtypes of cutaneous lymphoma. Arch Dermatol Res. 2014;306(9):843\u20139. https:\/\/doi.org\/10.1007\/s00403-014-1501-7.","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"732_CR51","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1038\/jid.2012.13","volume":"132","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Wang Y, Yu R, Huang Y, Su M, Xiao C, et al. Molecular markers of early-stage mycosis fungoides. J Investig Dermatol. 2012;132(6):1698\u2013706. https:\/\/doi.org\/10.1038\/jid.2012.13.","journal-title":"J Investig Dermatol"},{"issue":"6","key":"732_CR52","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.jaad.2018.06.025","volume":"79","author":"A Yuki","year":"2018","unstructured":"Yuki A, Shinkuma S, Hayashi R, Fujikawa H, Kato T, Homma E, et al. CADM1 is a diagnostic marker in early-stage mycosis fungoides: multicenter study of 58 cases. J Am Acad Dermatol. 2018;79(6):1039\u201346. https:\/\/doi.org\/10.1016\/j.jaad.2018.06.025.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"732_CR53","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.2340\/00015555-3306","volume":"99","author":"AH Rittig","year":"2019","unstructured":"Rittig AH, Lindahl LM, Johansen C, Celis P, Odum N, Iversen L, et al. The microRNA expression profile differs between erythrodermic mycosis fungoides and Sezary syndrome. Acta Derm Venereol. 2019;99(12):1148\u201353. https:\/\/doi.org\/10.2340\/00015555-3306.","journal-title":"Acta Derm Venereol"},{"issue":"12","key":"732_CR54","first-page":"7207","volume":"34","author":"U Ralfkiaer","year":"2014","unstructured":"Ralfkiaer U, Lindal L, Litman T, Gjerdrum L-M, Ahler CB, Gniadecki R, et al. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma. Anticancer Res. 2014;34(12):7207\u201317.","journal-title":"Anticancer Res"},{"issue":"4","key":"732_CR55","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3109\/10428194.2013.815352","volume":"55","author":"T Marstrand","year":"2014","unstructured":"Marstrand T, Ahler CB, Ralfkiaer U, Clemmensen A, Kopp KL, Sibbesen NA, et al. Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas. Leuk Lymphoma. 2014;55(4):957\u20138. https:\/\/doi.org\/10.3109\/10428194.2013.815352.","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"732_CR56","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.3390\/ijms18102136","volume":"18","author":"N Dusilkova","year":"2017","unstructured":"Dusilkova N, Basova P, Polivka J, Kodet O, Kulvait V, Pesta M, et al. Plasma miR-155, miR-203, and miR-205 are biomarkers for monitoring of primary cutaneous T-cell lymphomas. Int J Mol Sci. 2017;18(10):2136. https:\/\/doi.org\/10.3390\/ijms18102136.","journal-title":"Int J Mol Sci"},{"key":"732_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061409","author":"M Motamedi","year":"2021","unstructured":"Motamedi M, Xiao MZX, Iyer A, Gniadecki R. Patterns of gene expression in cutaneous T-cell lymphoma: systematic review of transcriptomic studies in mycosis fungoides. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10061409.","journal-title":"Cells"},{"issue":"16","key":"732_CR58","doi-asserted-by":"publisher","first-page":"adv00270","DOI":"10.2340\/00015555-3574","volume":"100","author":"LM Lindahl","year":"2020","unstructured":"Lindahl LM, Gluud M, Emmanuel T, Thomsen EA, Hu T, Rittig AH, et al. MicroRNA-106b regulates expression of the tumour suppressors p21 and TXNIP and promotes tumour cell proliferation in mycosis fungoides. Acta Derm Venereol. 2020;100(16):adv00270. https:\/\/doi.org\/10.2340\/00015555-3574.","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"732_CR59","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/bjd.20519","volume":"185","author":"L Moyal","year":"2021","unstructured":"Moyal L, Arkin C, Gorovitz-Haris B, Querfeld C, Rosen S, Knaneh J, et al. Mycosis fungoides-derived exosomes promote cell motility and are enriched with microRNA-155 and microRNA-1246, and their plasma-cell-free expression may serve as a potential biomarker for disease burden. Br J Dermatol. 2021;185(5):999\u20131012. https:\/\/doi.org\/10.1111\/bjd.20519.","journal-title":"Br J Dermatol"},{"issue":"4","key":"732_CR60","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/srt.12840","volume":"26","author":"M Zhu","year":"2020","unstructured":"Zhu M, Yu W, Wang P, Liu J, Li Z, Dai H, et al. Reflectance confocal microscopy may be included as part of the diagnostic algorithm of early-stage mycosis fungoides. Skin Res Technol. 2020;26(4):591\u20138. https:\/\/doi.org\/10.1111\/srt.12840.","journal-title":"Skin Res Technol."},{"issue":"3","key":"732_CR61","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/srt.12967","volume":"27","author":"B Melhoranse Gouveia","year":"2021","unstructured":"Melhoranse Gouveia B, Wells J, Kim J, Collgros H, Guitera P, Longo C, et al. Reflectance confocal microscopy role in mycosis fungoides follow-up. Skin Res Technol. 2021;27(3):414\u201321. https:\/\/doi.org\/10.1111\/srt.12967.","journal-title":"Skin Res Technol."},{"issue":"1","key":"732_CR62","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/jcm10010144","volume":"10","author":"YP Hsiao","year":"2021","unstructured":"Hsiao YP, Chiu CW, Lu CW, Nguyen HT, Tseng YS, Hsieh SC, et al. Identification of skin lesions by using single-step multiframe detector. J Clin Med. 2021;10(1):144. https:\/\/doi.org\/10.3390\/jcm10010144.","journal-title":"J Clin Med"},{"issue":"6","key":"732_CR63","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4132\/jptm.2020.07.11","volume":"54","author":"Y Chong","year":"2020","unstructured":"Chong Y, Lee JY, Kim Y, Choi J, Yu H, Park G, et al. A machine-learning expert-supporting system for diagnosis prediction of lymphoid neoplasms using a probabilistic decision-tree algorithm and immunohistochemistry profile database. J Pathol Transl Med. 2020;54(6):462\u201370. https:\/\/doi.org\/10.4132\/jptm.2020.07.11.","journal-title":"J Pathol Transl Med."}],"updated-by":[{"DOI":"10.1007\/s40257-023-00766-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000}}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-022-00732-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-022-00732-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-022-00732-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T03:31:37Z","timestamp":1678764697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-022-00732-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,18]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["732"],"URL":"https:\/\/doi.org\/10.1007\/s40257-022-00732-w","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s40257-023-00766-8","asserted-by":"object"}]},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,18]]},"assertion":[{"value":"19 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40257-023-00766-8","URL":"https:\/\/doi.org\/10.1007\/s40257-023-00766-8","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Helsinn Healthcare SA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"EH has served on scientific advisory boards of Actelion, Helsinn, Recordati Rare Diseases and Takeda, and speakers\u2019 bureaus for Helsinn, Rafa and Takeda. LG has received research support from Helsinn Group, J&J, Mallinckrodt, Kyowa Kirin, Soligenix, Innate, miRagen, Galderma, Merck, BMS and Stratpharma; and has served on speakers\u2019 bureaus for Helsinn Group and J&J, and scientific advisory boards for Helsinn Group, J&J, Mallinckrodt, Sanofi, Regeneron and Kyowa Kirin. EG has been a member of the scientific advisory board of Scailyte AG and has received grants and personal fees from Helsinn Healthcare, Kyowa Hakko Kirin and Takeda; and personal fees from Mallinckrodt Pharmaceuticals, Recordati, Novartis and Sanofi. PLO-R has served on advisory boards for Recordati Rare Diseases, Helsinn, 4SC, Innate Pharma, Kyowa Pharma Chemical Co., Takeda, miRagen Therapeutics and Actelion. RW has been a member of the scientific advisory board of Helsinn. JZ declares no conflicts of interest. RC has served as a consultant for Kyowa Kirin and as a member of the scientific advisory board for Helsinn Healthcare. FF has served as a consultant for Kyowa and Mallinkrodt. CM has served on advisory boards for Novartis, Helsinn, Bristol Myers Squibb, Sanofi and Pierre Fabre. CQ has served on advisory board\/scientific committees for Helsinn, Bioniz, miRagen, Trillium and Kyowa Kirin; and has received research funding from Celgene.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data sharing is\u00a0not applicable to this article as no datasets were generated or analyzed during the current study.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Prof. Hodak had full access to all the materials in the article and takes responsibility for the integrity and the accuracy of the analysis. All authors contributed to the study design and interpretation and reviewed and approved all manuscript drafts, including the final draft.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}